Have you been diagnosed with posttraumatic stress disorder (PTSD)? Are you suffering from symptoms such as nightmares or unwanted thoughts about a frightening or upsetting experience? Do you constantly feel on guard, watchful or easily startled? Do you avoid activities or places that you used to enjoy, or feel numb or detached from others, activities or your surroundings? You may be eligible to participate in a research study at Sharp Mesa Vista Hospital.
Participants must be:
- Over age 18
- Diagnosed with PTSD
This Phase 3, randomized, double-blind, placebo-controlled study will assess a study drug, brexpiprazole, as an adjunctive treatment in adults with PTSD. Participants will attend 13 clinic visits over 36 weeks. All study drugs will be provided as tablets to be taken once a day. This study is appropriate for individuals ages 18 to 65 who have been diagnosed with PTSD and still have frequent and severe symptoms and who have been experiencing PTSD symptoms for at least 3 months. The event triggering the PTSD must have occurred within the past 15 years. Learn more about this study.
How to Enroll
To learn more or to enroll in a clinical trial, call 858-836-8350 or send us an email.
For More Information
For information about other research studies at Sharp Mesa Vista Hospital, please visit Sharp Mesa Vista Clinical Research Center.
Please note that Sharp HealthCare does not control or endorse the information presented on external websites, nor do these websites endorse the information found on www.sharp.com.